Patent · US Active

Human hepatoma cell line HLCZ01 and uses thereof

US9989520B2 · kind B2 · utility

0Cited by

1References

11Claims

0Family size

Assignee

Hunan University · CN

Inventors

Haizhen Zhu · Changsha, CN
Chaohui Zuo · Changsha, CN
Xiaohong Wang · Roy, US
Darong Yang · Changsha, CN
Nianli Liu · Changsha, CN

Key dates

Filing date	May 10, 2013
Grant date	Jun 5, 2018
Priority date	—
Expiry date	May 10, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/91188
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

A human hepatoma cell line is HLCZ01 cell line which has been deposited in the China Center for Type Culture Collection (CCTCC), and having Accession (deposit) No. is CCTCC NO: C201309. The human hepatoma cell line HLCZ01 is used as a cell model supporting said hepatitis viruses infection and is used to establish an animal model for supporting virus infection, wherein said human hepatoma cell line HLCZ01 is also used for preparation, screening and evaluating anti-hepatitis virus drugs, anti-tumor drugs, and used for manufacturing artificial liver.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.